An Italian Observational Study to Evaluate Fracture Outcomes, Compliance to Treatment, Back Pain, Health-Related Quality of Life in Patients With Severe Osteoporosis Treated According to Common Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 05 May 2011
At a glance
- Drugs Teriparatide (Primary)
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Acronyms ISSO
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 05 May 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 05 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.